InvestorsHub Logo

rkrw

08/27/10 12:58 PM

#102733 RE: iwfal #102728

I've been told Nexavar has the same effect but only like 1-2% (I haven't checked to verify).

Competitively, GSK has a program a year or two behind and Plexxikon themselves have a 2nd generation program. So it will be interesting to see how they compare.

genisi

09/20/10 6:55 AM

#104597 RE: iwfal #102728

I've posted on the flip side of RAF inhibitors in #msg-47959017. If you find this issue fascinating like I do, read this paper:

http://www.nature.com/nature/journal/v464/n7287/full/464358a.html

(I can email it to you if you wish)